Manno, R., Bingham, C., Paternotte, S., Gossec, L., Halhol, H., Giacovell, G., . . . Dougados, M. (2011). OARSI–OMERACT initiative: Defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials. Osteoarthritis Cartilage.
Citação norma ChicagoManno, R.L., et al. "OARSI–OMERACT Initiative: Defining Thresholds for Symptomatic Severity and Structural Changes in Disease Modifying Osteoarthritis Drug (DMOAD) Clinical Trials." Osteoarthritis Cartilage 2011.
MLA citiranjeManno, R.L., et al. "OARSI–OMERACT Initiative: Defining Thresholds for Symptomatic Severity and Structural Changes in Disease Modifying Osteoarthritis Drug (DMOAD) Clinical Trials." Osteoarthritis Cartilage 2011.